Filing Flows › Comparisons › HSTA vs BDTB
Hestia Insight vs Bodhi Tree Biotechnology: HSTA and BDTB compared
Hestia Insight is the larger company: $16K of revenue in its latest quarter (Q2 FY26) against $10K for Bodhi Tree Biotechnology (Q3 FY26).
Where the money goes: HSTA and BDTB
Hestia Insight (HSTA) · Q2 FY26
Hestia Insight, Q2 FY26: revenue $16K, net loss $482K, operating cash flow −$32K. The chart follows the revenue to costs, profit and cash.
Bodhi Tree Biotechnology (BDTB) · Q3 FY26
Bodhi Tree Biotechnology, Q3 FY26: revenue $10K, operating margin -232.0%, net loss $23K, operating cash flow −$19K. The chart follows the revenue to costs, profit and cash.
| Hestia Insight (HSTA) | Bodhi Tree Biotechnology (BDTB) | |
|---|---|---|
| Latest quarter | Q2 FY26 | Q3 FY26 |
| Revenue | $16K | $10K |
| Operating margin | n/m | -232.0% |
| Net earnings | −$482K | −$23K |
| Net margin | — | -231.9% |
| Operating cash flow | −$32K | −$19K |
Questions
Which is bigger, Hestia Insight or Bodhi Tree Biotechnology?
Hestia Insight is the larger company: $16K of revenue in its latest quarter (Q2 FY26) against $10K for Bodhi Tree Biotechnology (Q3 FY26).
More: Hestia Insight earnings · how Hestia Insight makes money · Bodhi Tree Biotechnology earnings · how Bodhi Tree Biotechnology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Jul 20, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.